SPRINGWORKS THERAPEUTICS, INC. Operating Income
SPRINGWORKS THERAPEUTICS, INC. reported Operating Income of -$80.54 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-05-09
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-03-31 was -$80.54M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2024-12-31 was -$81.34M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2024-09-30 was -$57.94M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for the quarter ending 2024-06-30 was -$44.92M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for fiscal 2024 was -$278.13M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$343.01M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$280.67M.
- SPRINGWORKS THERAPEUTICS, INC. operating income (loss) for fiscal 2021 was -$173.47M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2025-03-31 | -$80.54M 10-Q · filed 2025-05-09 | -$161.88M derived: sum of 2 quarters · filed 2025-05-09 | -$219.81M derived: sum of 3 quarters · filed 2025-05-09 | -$264.74M derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2024-12-31 | -$81.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$139.28M derived: sum of 2 quarters · filed 2025-02-20 | -$184.20M derived: sum of 3 quarters · filed 2025-02-20 | -$278.13M 10-K · filed 2025-02-20 | ||
| 2024-09-30 | -$57.94M 10-Q · filed 2024-11-12 | -$102.86M derived: sum of 2 quarters · filed 2024-11-12 | -$196.79M 10-Q · filed 2024-11-12 | -$295.25M derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2024-06-30 | -$44.92M 10-Q · filed 2024-08-07 | -$138.85M 10-Q · filed 2024-08-07 | -$237.31M derived: sum of 3 quarters · filed 2025-05-09 | -$321.31M derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2024-03-31 | -$93.93M 10-Q · filed 2025-05-09 | -$192.39M derived: sum of 2 quarters · filed 2025-05-09 | -$276.39M derived: sum of 3 quarters · filed 2025-05-09 | -$359.25M derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2023-12-31 | -$98.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$182.46M derived: sum of 2 quarters · filed 2025-02-20 | -$265.31M derived: sum of 3 quarters · filed 2025-02-20 | -$343.01M 10-K · filed 2025-02-20 | ||
| 2023-09-30 | -$84.00M 10-Q · filed 2024-11-12 | -$166.85M derived: sum of 2 quarters · filed 2024-11-12 | -$244.55M 10-Q · filed 2024-11-12 | -$323.00M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-06-30 | -$82.85M 10-Q · filed 2024-08-07 | -$160.55M 10-Q · filed 2024-08-07 | -$239.00M derived: sum of 3 quarters · filed 2025-02-20 | -$310.75M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2023-03-31 | -$77.70M 10-Q · filed 2024-05-02 | -$156.15M derived: sum of 2 quarters · filed 2025-02-20 | -$227.89M derived: sum of 3 quarters · filed 2025-02-20 | -$296.90M derived: sum of 4 quarters · filed 2025-02-20 | ||
| 2022-12-31 | -$78.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$150.19M derived: sum of 2 quarters · filed 2025-02-20 | -$219.21M derived: sum of 3 quarters · filed 2025-02-20 | -$280.67M 10-K · filed 2025-02-20 | ||
| 2022-09-30 | -$71.74M 10-Q · filed 2023-11-02 | -$140.75M derived: sum of 2 quarters · filed 2023-11-02 | -$202.22M 10-Q · filed 2023-11-02 | -$258.02M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | -$69.01M 10-Q · filed 2023-08-02 | -$130.48M 10-Q · filed 2023-08-02 | -$186.28M derived: sum of 3 quarters · filed 2024-02-27 | -$227.17M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | -$61.47M 10-Q · filed 2023-05-03 | -$117.27M derived: sum of 2 quarters · filed 2024-02-27 | -$158.16M derived: sum of 3 quarters · filed 2024-02-27 | -$205.18M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | -$55.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$96.69M derived: sum of 2 quarters · filed 2024-02-27 | -$143.71M derived: sum of 3 quarters · filed 2024-02-27 | -$173.47M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | -$40.90M 10-Q · filed 2022-11-03 | -$87.92M derived: sum of 2 quarters · filed 2022-11-03 | -$117.67M 10-Q · filed 2022-11-03 | -$106.45M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | -$47.02M 10-Q · filed 2022-08-04 | -$76.78M 10-Q · filed 2022-08-04 | -$65.56M derived: sum of 3 quarters · filed 2023-02-28 | -$87.15M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$29.76M 10-Q · filed 2022-05-05 | -$18.54M derived: sum of 2 quarters · filed 2023-02-28 | -$40.13M derived: sum of 3 quarters · filed 2023-02-28 | -$59.95M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $11.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$10.37M derived: sum of 2 quarters · filed 2023-02-28 | -$30.19M derived: sum of 3 quarters · filed 2023-02-28 | -$46.32M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$21.59M 10-Q · filed 2021-11-04 | -$41.41M derived: sum of 2 quarters · filed 2021-11-04 | -$57.54M 10-Q · filed 2021-11-04 | -$74.91M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | -$19.82M 10-Q · filed 2021-08-04 | -$35.95M 10-Q · filed 2021-08-04 | -$53.32M derived: sum of 3 quarters · filed 2021-08-04 | -$68.65M derived: sum of 4 quarters · filed 2021-08-04 | ||
| 2020-03-31 | -$16.13M 10-Q · filed 2021-05-05 | -$33.50M derived: sum of 2 quarters · filed 2021-05-05 | -$48.83M derived: sum of 3 quarters · filed 2021-05-05 | -$63.68M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | -$17.37M 10-K · filed 2020-03-12 | -$32.70M derived: sum of 2 quarters · filed 2020-11-12 | -$47.55M derived: sum of 3 quarters · filed 2020-11-12 | -$59.24M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | -$15.33M 10-Q · filed 2020-11-12 | -$30.18M derived: sum of 2 quarters · filed 2020-11-12 | -$41.87M 10-Q · filed 2020-11-12 | -$48.32M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$14.85M 10-Q · filed 2020-08-12 | -$26.54M 10-Q · filed 2020-08-12 | -$32.99M derived: sum of 3 quarters · filed 2020-08-12 | -$38.22M derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | -$11.69M 10-Q · filed 2020-05-12 | -$18.14M derived: sum of 2 quarters · filed 2020-05-12 | -$23.36M derived: sum of 3 quarters · filed 2020-05-12 | -$27.59M derived: sum of 4 quarters · filed 2020-05-12 | ||
| 2018-12-31 | -$6.45M 10-K · filed 2020-03-12 | -$11.68M derived: sum of 2 quarters · filed 2020-03-12 | -$15.90M derived: sum of 3 quarters · filed 2020-03-12 | -$18.49M 10-K · filed 2021-02-25 | ||
| 2018-09-30 | -$5.23M 10-K · filed 2020-03-12 | -$5.23M 10-Q · filed 2019-11-12 | -$9.45M derived: sum of 2 quarters · filed 2020-03-12 | -$12.04M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$4.22M 10-K · filed 2020-03-12 | -$6.81M derived: sum of 2 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | -$2.59M 10-K · filed 2020-03-12 | |||||
| 2017-12-31 | -$4.66M 10-K · filed 2020-03-12 |